Dexlansoprazole MUPS

Product overview

Dexlansoprazole MUPS Pellets – Multiparticulate Platform for Flexible PPI Dosage Forms. Rraynex Dexlansoprazole MUPS Pellets are designed for pharmaceutical manufacturers developing multi-unit pellet systems requiring controlled particle characteristics and gastro-resistant protection. The platform supports flexible dosage-form development while maintaining focus on uniformity, coating integrity, dissolution, and downstream processability. Overview: Dexlansoprazole MUPS formulations use multiple coated units rather than a single monolithic dosage form, allowing flexibility in capsule and other multiparticulate presentations. Rraynex applies controlled pelletization and coating processes to support consistent distribution, moisture management, and release behavior. Key Features & Benefits: • Multi-unit pellet system suitable for PPI formulation development. • Controlled particle-size distribution. • Gastro-resistant coating platform. • Suitable for capsule and multiparticulate dosage forms. • Technical support for formulation optimization and scale-up. SEO Content: Rraynex offers Dexlansoprazole MUPS Pellets, Dexlansoprazole MUPS Manufacturer, Dexlansoprazole MUPS Supplier, Dexlansoprazole Pellets, MUPS Pellets, Multiple Unit Pellet System, PPI Pellets, Proton Pump Inhibitor Pellets, Enteric Coated Pellets, Gastro Resistant Pellets, Delayed Release Pellets, Multiparticulate Pellets, Capsule Filling Pellets, Pharmaceutical Pellets Manufacturer, Bulk Pharmaceutical Pellets, Pharmaceutical Pellet Supplier, GMP Pharmaceutical Manufacturer, CDMO, Pharmaceutical Exporter and Dexlansoprazole Manufacturer India.